openPR Logo
Press release

Urea Cycle Disorders Treatment Market Will Generate New Growth Opportunities By 2025

08-22-2018 08:15 AM CET | Health & Medicine

Press release from: Transparency Market Research

Urea Cycle Disorders Treatment Market Will Generate New Growth

Urea Cycle Disorder (UCD) is an assembly of rare genomic ailment which affects approximately 3,000 - 7000 people every year in the U.S. UCD is triggered by an alteration in genes, which causes insufficiency of any of the six vital enzymes essential for the urea cycle. Urea cycle includes a sequence of biochemical steps in which one of the waste products of protein metabolism (nitrogen) in blood is removed and progressively converted into a compound called urea. In end, urea in the blood is removed the body as urine. In UCD, nitrogen amasses in the form of ammonia, which is a highly poisonous substance for the body. It results into a precarious condition called hyperammonia (elevated levels of ammonia in blood). If the ammonia enters the brain cells via blood, it can lead to coma, irremediable brain damage, or in serious condition death.

According to reports published by the CDC (Centers for Disease Control and Prevention), the anticipated incidence of UCD is 1 in 8500 births. Research findings suggest that many of the cases of UCD persist undiagnosed. In some of the cases, the newborn with UCD dies without a conclusive diagnosis. The precise global incidence of such cases is underrated or unknown. Some of the scientists in Europe suggest that Sudden Infant Death Syndrome (SIDS) cases might be due to an unknown inborn error of metabolism, for example, UCD. These scenarios are anticipated to drive the urea cycle disorders treatment market in the next few years.

Obtain Report Details @ https://www.transparencymarketresearch.com/urea-cycle-disorders-treatment-market.html

Additionally, research & development initiatives undertaken by research & academic institutes supported by pharmaceutical companies as well as governments are estimated to drive the global urea cycle disorders treatment market. Consequently, want of diagnosis & treatment options, unavailability of skilled personnel, and lack of reimbursement policies in developing countries are some of the factors hindering the growth of global urea cycle disorders treatment market. The UCD treatment market is less competitive as compared to other markets as UCD is a rare disorder and no conclusive research regarding it has been conducted so far. Government and pharmaceutical companies need to create awareness in the market and collaborative approaches should be undertaken.

The global urea cycle disorders treatment market can be divided based on type of treatment, enzyme deficiency type, delivery channels, and region. On the basis of treatment type, the global urea cycle disorders treatment market can be classified into amino acid formulas, phenylbutyrate, sodium benzoate, and others. In terms of enzyme deficiency type, the global urea cycle disorders treatment market can be segregated into Carbamyl Phosphate Synthetase (CPS1), N-Acetylglutamate Synthetase (NAGS), Ornithine Transcarbamylase (OTC Deficiency), Argininosuccinic Acid Synthetase (AS), Argininosuccinate Lyase (AL or ASA Lyase), Arginase (AG).

Request For Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39329

Based on delivery channel, the global urea cycle disorders treatment market can be segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Geographically, the global urea cycle disorders treatment market can be bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The urea cycle disorders treatment market in North America is projected to expand rapidly in the next few years owing to the well-developed health care system, appropriate reimbursement scenario, and acceptance of the latest techniques in the region.

Following North America, the urea cycle disorders treatment market in Europe and Asia Pacific is anticipated to expand rapidly during the forecast period. Existence of well-established players, rise in investments in research and development by pharmaceutical giants, association of pharmaceutical and biotech companies with research institutes are some of drivers of the global urea cycle disorders treatment market.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=39329

Key players operating in the urea cycle disorders treatment market include Horizon Pharma plc. Lucane Pharma, Recordati Rare Diseases Inc., and Synlogic.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Urea Cycle Disorders Treatment Market Will Generate New Growth Opportunities By 2025 here

News-ID: 1192727 • Views: 126

More Releases from Transparency Market Research

Market Intelligence Report on Calcite Market, 2018-2028
Sales of calcite have witnessed utter proliferation in recent time, in line with the growing demand from paper and pulp sector wherein calcite is highly adopted as a coating and filler material. According to Transparency Market Research analysis, global calcite market is anticipated to register 4.7% CAGR during the study period 2018–2028. The TMR report opines that demand for calcite is highly driven by its significant properties that are paving way
Pearlescent Pigments Market Intelligence Report Offers Growth Prospects
The demand within the global pearlescent pigment market is slated to rise as new creative avenues emerge in the art and craft industry. Several artists have increased the consumption of pearlescent pigments, mainly due to the aesthetic value of these pigments in art forms. The use of these pigments can majorly be attributed to the gloss and shine imparted by these pigments to the design or craft. These pigments exhibit
Aragonite Market to Witness Steady Growth During the Forecast Period 2018-2026
Global Aragonite Market: Overview Aragonite is a carbonate mineral having an orthorhombic crystal system, and very closely resembles calcite. It is considered as the purest form of calcium carbonate. The mineral has garnered wide popularity as gemstone in various parts of the world and has promising healing properties with energy enhancing powers. Aragonite contains traces of magnesium and sand inclusion but rich in calcium carbonate, and is alkaline in nature. It
OEM Insulation Market Growth, Trends and Value Chain 2019-2027 by TMR
OEM Insulation Market – Overview OEM means Original Equipment Manufacturer that indicates to a company that produces a part or a subsystem of a product that is being used by another organization. Thermal insulation or simply insulation allows the product to cut down the heat gain or loss at the minimum by creating a barrier between the surfaces at the varying temperatures. There are wide range of applications and end-use verticals

All 5 Releases


More Releases for UCD

Urea Cycle Disorders (UCD) Treatment Market Analysis Focusing on Top Key Players …
"The new report has been added by qyresearch.com to provide detailed insight into the global Urea Cycle Disorders (UCD) Treatment market. The study will help to get a better understanding about the Urea Cycle Disorders (UCD) Treatment industry competitors, a channel for the distribution, Urea Cycle Disorders (UCD) Treatment growth potential, potentially disruptive trends, Urea Cycle Disorders (UCD) Treatment industry product innovations, market size value/volume (regional/country level, Urea Cycle Disorders
Global Urea Cycle Disorder Market Share, Size, Demands, Key Company Analysis and …
Urea cycle disorders (UCDs) are a group of orphan inherited defects of six enzymes and two transporters that constitute the urea cycle in the periportal liver cells. The age of onset symptoms vary between the different types of UCDs. Order a copy of this “Global Urea Cycle Disorder Market “report @ http://www.marketreportsonline.com/contacts/purchase.php?name=785316. UCDs often occurs during the period of infancy due to triggered postnatal catabolism. The diagnosis is made by
Urea Cycle Disorders (UCD) Treatment Market to Reflect Impressive Expansion Duri …
According to national urea cycle disorders foundation of USA, a urea cycle disorder is a genetic disorder caused by a mutation that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. The urea cycle involves a series of biochemical steps in which nitrogen, a waste product of protein metabolism, is removed from the blood
Urea Cycle Disorders Treatment Market: Latest Trends, Demand and Analysis 2017 …
Urea Cycle Disorders Treatment Market -Overview Urea Cycle Disorder (UCD) is an assembly of rare genomic ailment which affects approximately 3,000 – 7000 people every year in the U.S. UCD is triggered by an alteration in genes, which causes insufficiency of any of the six vital enzymes essential for the urea cycle. Urea cycle includes a sequence of biochemical steps in which one of the waste products of protein metabolism (nitrogen)
Urea Cycle Disorders (UCD) Treatment Market Expected to Rise Steadily throughout …
According to national urea cycle disorders foundation of USA, a urea cycle disorder is a genetic disorder caused by a mutation that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. The urea cycle involves a series of biochemical steps in which nitrogen, a waste product of protein metabolism, is removed from the blood
Market Research on Urea Cycle Disorders (UCD) Treatment Market 2017 and Analysis …
According to national urea cycle disorders foundation of USA, a urea cycle disorder is a genetic disorder caused by a mutation that results in a deficiency of one of the six enzymes in the urea cycle. These enzymes are responsible for removing ammonia from the blood stream. The urea cycle involves a series of biochemical steps in which nitrogen, a waste product of protein metabolism, is removed from the blood